A New Jersey woman says she used the GLP-1 medication Mounjaro during cancer treatment and later heard that the drug could help reduce the risk of cancer returning. In the accounts provided, Leila Gonzalez, 53, is described as having been diagnosed with tumors in her right breast while she was clinically obese at the time of diagnosis. The reports focus on her personal experience using GLP-1 injections during her cancer care and highlight that doctors are considering whether this class of drugs may play a role in lowering recurrence risk. The articles do not provide detailed results from clinical trials or specify the exact stage of her cancer, the treatments she received alongside Mounjaro, or how her doctors assess the drug’s effect. Overall, the coverage presents her story as an example while pointing to ongoing medical interest in the potential relationship between GLP-1 therapies and cancer outcomes. The information is framed around a patient narrative rather than new, widely reported clinical evidence.